INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19
12/08/2020

INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19

PLYMOUTH MEETING, Pa., Dec. 7, 2020 /PRNewswire/ — INOVIO (NASDAQ: INO), a biotechno...
read more
Promising phase 1 trial results: Use of sotorasib (AMG 510) in patients with solid tumors
09/21/2020

Promising phase 1 trial results: Use of sotorasib (AMG 510) in patients with solid tumors

A phase 1 clinical trial of sotorasib (AMG 510) in...
read more
Phase III trials of coronavirus vaccine to take place at 5 US military sites, Pentagon confirms
09/04/2020

Phase III trials of coronavirus vaccine to take place at 5 US military sites, Pentagon confirms

Pentagon confirms Phase III trials of coronavirus ...
read more
Urovant Sciences Announces Positive Topline Results from Pivotal Phase 3 EMPOWUR Study of Vibegron in Patients with Overactive Bladder
03/20/2019

Urovant Sciences Announces Positive Topline Results from Pivotal Phase 3 EMPOWUR Study of Vibegron in Patients with Overactive Bladder

IRVINE, Calif. & BASEL, Switzerland–(BUS...
read more